SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII)
NTII 0.00010000.0%Dec 26 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Boyce Burge who wrote (9)10/8/1996 12:15:00 PM
From: scaram(o)uche   of 1494
 
I have mixed feelings about Tracy's recommendations. He also picked CORX. :-)

John De Castro has discussed CNSI and Cerestat extensively, and I'll leave a response regarding potential competition to him. I can only say that you'd be blown away after talking with Stuart Lipton. Of any agent described to date, I'd want memantine following a stroke.

And, I wouldn't discount NTII's efforts with edema (rheumatoid arthritis and brain trauma) and opiate adjuvants.

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext